OmniAb Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: OABI
Share price (8/21/26): $4.33
Market cap (8/21/26): $630 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 425 13 pages Amended and Restated Forward Purchase Agreement

from 8-K 13 pages Amended and Restated Forward Purchase Agreement

from 8-K 9 pages Avista Public Acquisition Corp. II 65 East 55th Street, 18th Floor New York, Ny 10022 Re: Letter Agreement Ladies and Gentlemen

from 425 9 pages Avista Public Acquisition Corp. II 65 East 55th Street, 18th Floor New York, Ny 10022 Re: Letter Agreement Ladies and Gentlemen

from 425 70 pages Separation and Distribution Agreement by and Among Ligand Pharmaceuticals Incorporated, Omniab, Inc. and Avista Public Acquisition Corp. II Dated as of March 23, 2022

from 8-K 70 pages Separation and Distribution Agreement by and Among Ligand Pharmaceuticals Incorporated, Omniab, Inc. and Avista Public Acquisition Corp. II Dated as of March 23, 2022

from 425 370 pages Agreement and Plan of Merger Dated as of March 23, 2022 by and Among Ligand Pharmaceuticals Incorporated, Omniab, Inc., Avista Public Acquisition Corp. II and Orwell Merger Sub Inc. -I

from 8-K 370 pages Agreement and Plan of Merger Dated as of March 23, 2022 by and Among Ligand Pharmaceuticals Incorporated, Omniab, Inc., Avista Public Acquisition Corp. II and Orwell Merger Sub Inc. -I